Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
06/2003
06/19/2003US20030114648 Method of protein purification
06/19/2003US20030114417 Producing of a large amount of gamma-cyclodextrin from the substrates from starch and starch decomposition products, e.g., dextrin, amylopectin and amylose; recombinant plasmids; food additive; stabilizers; emulsifiers; drugs; cosmetics
06/19/2003US20030114410 Angiogenesis inhibition by administering into the tissue a molecule ,e.g., novel platelet factor 4 binding protein, to deactivate a lysyl oxidase; antimetastasis, -carcinogenic and -tumor agents; suppression of fibrosis
06/19/2003US20030114409 Facilitation of RNA interference
06/19/2003US20030114401 Antisense modulation of Ship-1 expression
06/19/2003US20030114387 Gamma secretase inhibitors
06/19/2003US20030114382 Angiogenesis inhibition
06/19/2003US20030114373 Polypeptides for treating neuro- and musculo-degenerative conditions, drug screening for identifying agonists and antagonists
06/19/2003US20030114368 Immunotoxins directed against malignant cells
06/19/2003US20030114330 BGL5 beta-glucosidase and nucleic acids encoding the same
06/19/2003US20030113920 Transducting, dividing cells; gene expression; gene therapy
06/19/2003US20030113895 Proteases from gram-positive organisms
06/19/2003US20030113894 Therapy for kidney diseases; cardiovascular disorders
06/19/2003US20030113893 D-aminoacylases, method for producing the same, and method for producing D-amino acids using the same
06/19/2003US20030113887 Use of restriction endonuclease I-SceI for mapping eukaryotic genomes and for in vivo site directed genetic recombination
06/19/2003US20030113884 Genetic engineering; using enzyme; isolated nucleic acids
06/19/2003US20030113882 With use of lysine-2,3-aminomutase as catalyst; enantiomorphic purity
06/19/2003US20030113881 D-enzyme compositions and methods of their use
06/19/2003US20030113880 DNA for encoding D-hydantoin hydrolases, DNA for encoding N-carbamyl-D-amino acid hydrolases, recombinant DNA containing the genes, cells transformed with the recombinant DNA, methods for producing proteins utilizing the transformed cells and methods for producing D-amino acids
06/19/2003US20030113879 Citrate lyase E (cit e); animal feeds/husbandry; nutraceuticals
06/19/2003US20030113864 Induction of chondrocyte proliferation/differentiation; antitumor agents; antiinflammatory agents; antiproliferative agents; anticarcinogenic agents; antisense agents; cancer diagnosis
06/19/2003US20030113863 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113862 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113861 Induction of chondrocyte differentiation/proliferation; antitumor agents; antiinflammatory agents; antiproliferative agents; anticarcinogenic agents; antisense agents; cancer diagnosis
06/19/2003US20030113859 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113858 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113857 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113856 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113855 Induction of chondrocyte proliferation/differentiation; antitumor agents; antiinflammatory agents; antiproliferative agents; anticarcinogenic agents; antisense agents; cancer diagnosis
06/19/2003US20030113852 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113851 Induction of chondrocyte differentaition/proliferation; antitumor agents; antiinflammatory agents; antiproliferative agents; anticarcinogenic agents; antisense agents; cancer diagnosis
06/19/2003US20030113849 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113848 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113846 Lipases; lipooxygenases; phospholipases; neuroprotectants; antiinflammatory agents; bradycardial agents; antitumor agents
06/19/2003US20030113845 Lyases; bactericides; gene knockout; animal husbandry
06/19/2003US20030113843 For stimulating release of tumor necrosis factor, and/or cell proliferation/differentiation of chrondrocytes by contacting blood with polypeptides; antiinflammatory agents; anticarcingenic agents; antitumor agents; cancer diagnosis
06/19/2003US20030113842 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113838 Epidermal growth factor; antitumor agents; antiproliferative agents; antiinflammatory agents; mitogen-activated protein kinases
06/19/2003US20030113837 Tyrosine recombinase for genetic engineering
06/19/2003US20030113836 In vitro translation; protease inhibitors; fibroin
06/19/2003US20030113835 Methods for protein synthesis, protein screening and retrieval of protein function
06/19/2003US20030113795 Membrane protein; cytokines; antitumor agents; anticarcinogenic agents; antiinflammatory agents; cancer diagnosis
06/19/2003US20030113793 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113790 26343, a novel human oxidoreductase and uses therefor
06/19/2003US20030113777 Methods and compositions for the treatment and diagnosis of cellular proliferative disorders using 32222
06/19/2003US20030113775 7118, a human arginine N-methyltransferase family member and uses therefor
06/19/2003US20030113760 Transforming cancerous tissue making it sensitive to antiproliferative agents and viricidal agents; suicide gene therapy; cancer diagnosis
06/19/2003US20030113749 Interaction trap systems for detecting protein interactions
06/19/2003US20030113747 Genetically engineered adenosine triphosphate generating polypeptide; sequences determination; reporter molecules
06/19/2003US20030113743 Method for detection of micrometastatic prostate cancer
06/19/2003US20030113735 Glucanases/glucosidase/hydrolases; conversion of cellulose to sugars and/or ethanol; laundering detergents
06/19/2003US20030113734 EGVII endoglucanase and nucleic acids encoding the same
06/19/2003US20030113732 EGVI endoglucanase and nucleic acids encoding the same
06/19/2003US20030113726 Human single nucleotide polymorphisms
06/19/2003US20030113719 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113718 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113711 Protein kinase peptide substrate determination using peptide libraries
06/19/2003US20030113407 Transglutaminase gene of Streptoverticillium ladakanum and the transglutaminase encoded therefrom
06/19/2003US20030113368 Holding capability for hydrophilic and lipophilic drugs, water-soluble and hydrophobic substaces; controlling sustained release
06/19/2003US20030113329 An isolated polynucleotide encoding the enzyme polypeptide, genetic engineering, diagnostic kit, drug screening, antibodies; theraptic treatment of cancer, anemia, and end-stage renal disease
06/19/2003US20030113311 Pertussis toxin and analogs exhibit an adenosine-5* diphosphate-ribosyltransferase activity, useful in promoting prophylactic and/or therapeutic responses against another target antigen in a mammal patient
06/19/2003US20030113308 Contacting the biological fluid with at least one oxalate-degrading enzyme immobilized on a surface; reduces the incidence of scale
06/19/2003US20030113298 Applying the lytic protein, peptides, or peptide fragments to the mucosal surface, produced by infecting a bacterium causing infection with a bacteriophage specific for the bacteria
06/19/2003US20030113294 Introducing into the mammalian cell an agent containing DNA or RNA encoding and expressing a protein tyrosine phsphatase polypeptide, which catalyzes dephosphorylation of tyrosyl residue
06/19/2003US20030113271 Comprises plasminogen activator and surfactant to promote fibrinolysis and/or reduce inflammation; aerosols
06/19/2003CA2848193A1 Method for modifying plant morphology, biochemistry and physiology comprising expression of plant cytokinin oxidase
06/19/2003CA2474152A1 Methods and materials for the production of organic products in cells of candida species
06/19/2003CA2472054A1 Compositions and methods for normalizing assays
06/19/2003CA2470125A1 Biocompatible membranes of block copolymers and fuel cells produced therewith
06/19/2003CA2469695A1 Methods for the identification of inhibitors of asparagine synthase, 5-aminolevulinate synthase, histidinol-phosphatase, 3-isopropylmalate and threonine synthase as antibiotics
06/19/2003CA2469679A1 Heme-regulated eukaryotic initiation factor 2 alpha kinase knockout mice and methods for use
06/19/2003CA2469484A1 Method of isolation and purification of trypsin from pronase and use thereof
06/19/2003CA2469274A1 Tumor antigens
06/19/2003CA2468753A1 Method for modifying plant morphology, biochemistry and physiology comprising expression of plant cytokinin oxidase
06/19/2003CA2467721A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
06/19/2003CA2467689A1 Stabilization of hypoxia inducible factor (hif) alpha using inhibitors of hif prolyl hydroxylase
06/19/2003CA2467505A1 Expression system
06/18/2003EP1319719A1 Reversibly modified thermostable enzymes for DNA synthesis and amplification in vitro
06/18/2003EP1319715A1 IMP dehydrogenase and its use for the identification of fungicidal substances
06/18/2003EP1319709A1 Disruption of the glutathione S-transferase-omega-1 gene
06/18/2003EP1319087A2 PROCESS FOR THE PREPARATION OF A $g(b)-LACTAM NUCLEUS AND THE APPLICATION THEREOF
06/18/2003EP1319084A1 Nucleotide sequences which code for the mene gene
06/18/2003EP1319079A1 Talaromyces xylanase
06/18/2003EP1319078A2 38692 and 21117: dual specificity phosphatase molecules and uses therefor
06/18/2003EP1319077A2 Nucleotide sequences which code for the tmk gene
06/18/2003EP1319076A1 Nucleotide sequences coding for the thya gene
06/18/2003EP1319074A2 Process for producing peptides by using i in vitro /i transcription/translation system
06/18/2003EP1319073A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding them, and uses thereof
06/18/2003EP1319067A2 Human coagulation factor vii variants
06/18/2003EP1319066A2 Isolated human kinase proteins, nucleic acid molecules and uses thereof
06/18/2003EP1319065A1 Nucleotide sequences which code for the ndka gene
06/18/2003EP1319064A2 Gsk3 polypeptides
06/18/2003EP1318841A2 Control of nk cell function and survival by modulation of ship activity
06/18/2003EP1109823A4 Modifications of the vegf receptor-2 protein and methods of use
06/18/2003EP0815241B1 Identification and cloning of a mobile transposon from aspergillus
06/18/2003CN1425071A Mutant apre promoter
06/18/2003CN1425070A Rice-origin gibberellin 2 & š�-hydroxylase genes and utilization thereof
06/18/2003CN1425069A Method for purifying proteins
06/18/2003CN1425065A Method of controlling telomere length
06/18/2003CN1425063A Lactic acid bacteria overproducing exopolysaccharides
1 ... 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 ... 1416